How academic medicine can confront commercial determinants of health
BMJ · 10.11.2026 · 395 · e101243
DOI: 10.1136/bmj-2026-101243 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, online erschienen am 10.11.2026. Verfasst von Jennifer Lacy-Nichols und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Society, Melbourne School of Public Health, University of Melbourne, Melbourne, Australia jlacy@unimelb.edu.au. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Academic medicine has a crucial role in exposing and minimising the harms created by businesses that prioritise profit over health, though teaching and training, research, and advocacy, argue Jennifer Lacy-Nichols and colleagues
Autor:innen und Institutionen
- Department of Health and Society, Melbourne School of Public Health, University of Melbourne, Melbourne, Australia jlacy@unimelb.edu.au.
- South African Medical Research Council/Wits Centre for Health Economics and Decision Science (PRICELESS SA), School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
- School of Public Health, University of Nevada, Reno, USA.
Zitieren
APA
Lacy-Nichols, J., Goldstein, S., & Crosbie, E. (2026). How academic medicine can confront commercial determinants of health. BMJ, 395, e101243. https://doi.org/10.1136/bmj-2026-101243
Vancouver
Lacy-Nichols J, Goldstein S, Crosbie E. How academic medicine can confront commercial determinants of health. BMJ. 2026;395:e101243. doi:10.1136/bmj-2026-101243
BibTeX
@article{LacyNichols2026,
author = {Lacy-Nichols, Jennifer and Goldstein, Susan and Crosbie, Eric},
title = {How academic medicine can confront commercial determinants of health},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101243},
doi = {10.1136/bmj-2026-101243}
}
EUVIMED